AstraZeneca-Merck Lynparza gets EMA's positive recommendation

Drugmakers AstraZeneca Plc and Merck& Co Inc said on Monday their blockbluster cancer drug, Lynparza, has received positive recommendation from the European Medicines Agency (EMA) as a maintenance treatment for a form of pancreatic cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news